JournalQ1· SCImago 2025
Clinical Cancer Research
ISSN 1078-0432
- Q1Quartile
- 4.00SJR
- 405h-index
- 4papers summarised
About this journal
Clinical Cancer Research is a Q1 journal by SCImago Journal Rank (2025 data), with an SJR of 4.00 and an h-index of 405. Most of its papers in the Pofolia pool fall under Hepatology. Pofolia holds AI summaries of 4 paper(s) from this journal; the most cited is “FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High…” (1165 citations).
The quartile (Q1–Q4) is the journal's percentile position within its subject area by SCImago Journal Rank; Q1 is the top 25%. What is a Q1 journal?
Papers we summarise from this journal
- FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors2019 · 1165 citations
- Deep Learning–Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer2017 · 1088 citations
- Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas2014 · 662 citations
- Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors2014 · 582 citations
Journals in the same field
| Journal | Quartile | SJR | Summaries |
|---|---|---|---|
| Cell | Q1 | 24.00 | 1 |
| New England Journal of Medicine | Q1 | 18.00 | 10 |
| Signal Transduction and Targeted Therapy | Q1 | 17.00 | 1 |
| Journal of Hepatology | Q1 | 13.00 | 1 |
| Science | Q1 | 10.00 | 1 |
| Nature Reviews Gastroenterology and Hepatology | Q1 | 9.00 | 1 |
| Gut | Q1 | 8.00 | 1 |
| Hepatology | Q1 | 7.00 | 9 |
| JAMA Oncology | Q1 | 7.00 | 1 |
| JAMA | Q1 | 5.00 | 1 |
See every journal in the field →
Follow these journals on Pofolia
Pick your fields and new papers from their journals land in your feed every day with AI summaries. Free.
Start free